Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

聚乙二醇钠钾散 - NMPA Drug Approval Details

Approvals/NMPA/Macrogol Sodium Potassium Powder

Approved

化学药品

Macrogol Sodium Potassium Powder

海南紫程众投生物科技有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 30, 2025
Approval ID: 8mdl4ODzwis
Company: 海南紫程众投生物科技有限公司
Type: 化学药品

Approval Details

Approval Id: 8mdl4ODzwis
Approval Number: 国药准字H20256496
Generic Name: 聚乙二醇钠钾散
Generic Name En: Macrogol Sodium Potassium Powder
Drug Type: 化学药品
Dosage Form: 散剂
Strength: 本品为复方制剂，每包含聚乙二醇3350为13.1250g、氯化钠0.3507g、氯化钾0.0466g、碳酸氢钠0.1785g
Reg Date: 2025-12-30
Company Name: 海南紫程众投生物科技有限公司
Company Address: 海南省海口市国家高新技术产业开发区科技大道22号海口国科中心B座301室
Production Company Name: 南京海纳制药有限公司
Production Company Address: 南京市江北新区科创大道18号
Company Detail Path: /organization/23c3a6db1234e3d0/hai-nan-zi-cheng-zhong-tou-sheng-wu-ke-ji-you-xian-gong-si
Production Company Detail Path: /organization/41acef05e76c44fe/nan-jing-hai-na-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 30, 2025

Approval ID

8mdl4ODzwis

Type

化学药品

Back to NMPA Approvals